1. Home
  2. MYO vs YI Comparison

MYO vs YI Comparison

Compare MYO & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.01

Market Cap

33.2M

Sector

Health Care

ML Signal

HOLD

Logo 111 Inc.

YI

111 Inc.

N/A

Current Price

$3.60

Market Cap

38.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
MYO
YI
Founded
2004
2010
Country
United States
China
Employees
N/A
N/A
Industry
Industrial Specialties
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
33.2M
38.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
MYO
YI
Price
$1.01
$3.60
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$7.67
N/A
AVG Volume (30 Days)
830.5K
13.5K
Earning Date
11-10-2025
12-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,643,203.00
$1,979,883,442.00
Revenue This Year
$24.07
N/A
Revenue Next Year
$17.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
65.00
N/A
52 Week Low
$0.71
$3.19
52 Week High
$7.17
$11.35

Technical Indicators

Market Signals
Indicator
MYO
YI
Relative Strength Index (RSI) 55.55 40.27
Support Level $1.02 $3.32
Resistance Level $1.13 $3.94
Average True Range (ATR) 0.07 0.21
MACD 0.02 0.02
Stochastic Oscillator 59.57 44.59

Price Performance

Historical Comparison
MYO
YI

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: